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Depression represents one of the most common comorbidities in patients with epilepsy. However, the mecha-
nisms of depression in epilepsy patients are poorly understood. Establishment of animal models of this comor-
bidity is critical for both understanding the mechanisms of the condition, and for preclinical development of
effective therapies. The current study examined whether a commonly used animal model of temporal lobe
epilepsy (TLE) is characterized by behavioural and biochemical alterations involved in depression. Male Wistar
rats were subjected to LiCl and pilocarpine status epilepticus (SE).The development of chronic epileptic state
was confirmed by the presence of spontaneous seizures and by enhanced brain excitability. Post-SE animals
exhibited increase in immobility time under conditions of forced swim test (FST) which was indicative of
despair-like state, andloss oftaste preferencein saccharin solution consumptiontest which pointedtothe symp-
tomatic equivalence of anhedonia. Biochemical studies revealed compromised serotonergic transmission in the
raphe-hippocampal serotonergic pathway: decrease of serotonin (5-HT) concentration and turnover in the hip-
pocampus, measured by high performance liquid chromatography, and decrease of 5-HTrelease from the hip-
pocampus in response to raphe stimulation, measured by fast cyclic voltammetry. Administration of fluoxetine
(FLX, 20 mg/kg/day for 10 days) to naive animals significantly shortened immobility time under conditions of
FST, and inhibited 5-HT turnover in the hippocampus. In post-SE rats FLX treatment led to a further decrease
of hippocampal 5-HT turnover; however, performance in FST was not improved. At the same time, FLX
reversed SE-induced increase in brain excitability. In summary, our studies provide initial evidence that post-SE
modelof TLEmight serve as a modelof the comorbidityof epilepsy anddepression.The finding that behavioural
equivalents of depression were resistant to an antidepressant medication suggested that depression in epilepsy
might have distinct underlying mechanisms beyond alterations in serotonergic pathways.
Keywords: comorbidity; depression; epilepsy; hippocampus; serotonin
Abbreviations: 5-HT=serotonin; 5-HIAA=5-hydroxyindolacetic acid; ADT=afterdischarge threshold;
ADD=afterdischarge duration; FCV=fast cyclic voltammetry; FLX=fluoxetine; FST=forced swim test; HPLC=high
performance liquid chromatography; PCA=parachloroamphetamine; SE=status epilepticus; SERT=serotonin transporter;
SSRI=selective serotonin reuptake inhibitors;TLE=temporal lobe epilepsy.
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Introduction
Depression represents one of the most common comorbid-
ities in patients with epilepsy (Kanner and Balabanov, 2002;
Harden, 2002). While psychosocial aspects of being in the
epileptic state may contribute to depression associated with
epilepsy, there is a growing consensus that this condition
has neurobiological basis (Kanner, 2005). For example,
both clinical and experimental evidence suggest that the
imbalances in such neurotransmitters as GABA, glutamate,
norepinephrine and serotonin, which are commonly
observed in epilepsy patients, may concurrently contribute
to the evolvement of depression (Kanner and Balabanov,
2002; Jobe, 2003; Kanner, 2005; Kondziella et al., 2007).
One clinical study emphasized comparable impairments in
the functioning of hypothalamic pituitary adrenocortical
system in patients with epilepsy and those with depression
doi:10.1093/brain/awn117 Brain (2008),131, 2071^2083
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 (Zobel et al., 2004). A number of clinical reports have
implicated hippocampal neurodegeneration (e.g. Cascino
et al., 1991; Sheline et al., 1996), or dysfunction (Gilliam
et al., 2007) in the development of depression in epilepsy
patients, although few studies have suggested otherwise
(Briellmann et al., 2007; Richardson et al., 2007).
Establishment and validation of animal models of com-
orbidity between epilepsy and depression is instrumental
for both understanding the mechanisms of the condition,
and for preclinical development of effective therapies. For
example, depression has been described in Wag-Rij inbred
rats, which exhibit spontaneous absence seizures (Sarkisova
et al., 2003), and in genetic absence epilepsy rats from
Strasbourg (GAERS, Jones et al., 2008). However reports on
depression-like disorders associated with experimental tem-
poral lobe epilepsy (TLE) are scarce and controversial.
Thus, Mortazavi et al. (2005) reported increased behav-
ioural despair under conditions of forced swim test (FST)
in pentylenetetrazole-kindled rats. We recently described
anhedonia and despair in animals that had been subjected
to rapid kindling in young age (Mazarati et al., 2007).
However, Ma and Leung (2004) found no changes in forced
swimming behaviour after amygdala kindling. Adamec et al.
(2004) and Wintink et al. (2003) failed to reveal any
changes in taste preference in animals which had been
subjected to kindling. Koh et al. (2007) reported changes in
FST in juvenile rats following kainic acid induced status
epilepticus (SE). In contrast, Groticke et al. (2007) found
an improved performance under conditions of FST in post-
pilocarpine SE model of epilepsy in mice, as compared to
non-epileptic controls. Clearly, more efforts are required in
the pursuit of validation of available models of epilepsy as a
comorbidity between the two states.
The current study had several goals. First, we examined
whether depression developed under conditions of a
commonly used model of TLE, namely post-SE chronic
epilepsy in the rat. Second, in addition to characterizing the
behavioural symptoms of depression, we studied some
neurochemical correlates of the comorbidity. Among mul-
tiple candidate mechanisms we selected serotonergic trans-
mission as a target for initial experiments. On the one
hand, serotonin (5-HT) deficiency is not only a mechanism
of depression (Jobe et al., 1999; Kondziella et al., 2007), but
is also a defining approach in the treatment of the
disease through the use of selective serotonin reuptake
inhibitors (SSRI). On the other hand, dysfunction of
serotonergic transmission has been reported under condi-
tions of TLE (Theodore, 2003). It was suggested that
impairments in serotonergic transmission represent a
pathophysiological link between epilepsy and depression
(Jobe et al., 1999). Finally, we examined whether treatment
with a clinically available and widely used antidepressant—
SSRI fluoxetine (FLX), would improve both behavioural
and biochemical impairments indicative of depression in
post-SE animals.
Materials and Methods
The study design is shown in Fig. 1.
Animals
The experiments were performed in male Wistar rats (Charles
River, Wilmington, MA, USA), 34 days of age at the beginning of
the study. The experiments were done in accordance with the
policies of the National Institutes of Health and the UCLA Office
for the Protection of Research Subjects.
Status epilepticus
Animals received an intraperitoneal (i.p.) injection of LiCl
(130mg/kg, Sigma, St. Louis, MO, USA). On the next day (i.e.
at the age of 35 days) animals were injected subcutaneously (s.c.)
with atropine methyl bromide (10mg/kg, Sigma) to alleviate
peripheral effects of pilocarpine, and 30min later were injected s.c.
with pilocarpine hydrochloride (40mg/kg, Sigma). SE was
characterized by continuous limbic seizures which started 10–
15min after pilocarpine injection. At their peak, seizure behaviour
consisted of rearing or rearing and falling, which corresponded to
stages 4–5 on the Racine (1972) scale. Those animals that failed to
develop stage 4–5 seizures were excluded from further studies.
After 3 and 8h of seizure onset, rats were injected i.p. with
diazepam (5mg/kg) and phenytoin (50mg/kg), in order to
alleviate further seizures and to increase survival. Control animals
received injections of LiCl, atropine, diazepam and phenytoin, and
saline in lieu of pilocarpine.
Surgery
After 21–24 days of SE (or after atropine and antiepileptic drugs
injections in control rats), under isoflurane anaesthesia animals
Fig. 1 Study design.Veh=vehicle.
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 were stereotaxically implanted with a bipolar stimulating electrode
(Plastics one, Roanoke, VA, USA) into the ventral hippocampus
(4.8mm posterior and 5.3 left from Bregma, 6.5mm down from
brain surface; Paxinos and Watson, 1986). A tripolar recording
electrode (Plastics one Inc.) was wrapped around skull screws
using the nasal bone as the ground. The electrodes were fixed to
the skull with Cerebond adhesive (MyNeurolab.com, St. Louis,
MO, USA). Animals were allowed to recover between 3 and 7 days
before further studies.
Recording and analysis of spontaneous seizures
Four weeks after SE animals were placed in the observation
chambers with free access to food and water (Instech Solomon,
Plymouth Meeting, PA, USA). Recording electrodes were con-
nected to MP100/EEG100C acquisition system (BIOPAC Systems
Inc., Santa Barbara, CA, USA), via low-torque commutator swivels
(Plastics One). EEG was continuously acquired for a period of one
week using AcqKnowledge 3.82 software (BIOPAC). Incidence and
frequency of spontaneous seizures were analysed off-line.
Behavioural tests
Starting from the next day after the end of seizure monitoring in
post-SE animals, or on the congruent day in the control group, we
evaluated depressive behaviour using two consecutive tests: taste
preference to examine a behavioural correlate of anhedonia (i.e.
inability to experience pleasure), and FST to study the ability to
adapt active strategy in an inescapable stressful situation.
The study of taste preference was performed using the saccharin
solution consumption test (Pucilowski et al., 1993; Moreau, 1997;
Mazarati et al., 2007). The animals had free access to a standard
rodent diet. On the first day (habituation), each cage was supplied
with two identical graduated water bottles, each containing 250ml
of water. On the next day (test), regular water in one of the
bottles was replaced with 0.1% saccharin (Sigma, St. Louis, MO,
USA) diluted in tap water. The test was performed starting from
5:00 PM and ran for 24h. Taste preference was expressed as
percent of the volume of saccharin solution of a total volume of
fluid (saccharin plus regular water) consumed over 24h.
We employed a modified version of the FST in which the
animals underwent a single 5-min trial. This modification of the
classic Porsolt test (1979) was shown to be relevant for both
examining depressive-like state and for screening antidepressant
agents (Pucilowski and Overstreet 1993; Overstreet et al., 1995;
Mazarati et al., 2007).
The test was performed the day after the taste preference
experiment. In each trial, the animal was placed for 5min in a
plastic container (60cm in height and 30cm in width) filled with
tap water to a height of 45cm, and maintained at 22–25 C. After
each test, the container was washed and refilled with fresh water.
Swimming behaviour was videotaped and analysed offline by an
investigator blinded to treatment. Total immobility time was
calculated. Immobility was defined as moving the limbs just
enough to stay above water, as opposed to escaping or exploring
behaviour.
Afterdischarge properties
After the end of the behavioural tests, afterdischarge properties
were examined in both post-SE and control animals. A stimulating
electrode was connected to a DS8000 stimulator via a DLS100
stimulus isolator [World Precision Instruments Inc. (WPI),
Sarasota, FL, USA]; a recording electrode was connected to the
EEG acquisition system (BIOPAC) as described earlier.
Afterdischarge threshold (ADT) and duration (ADD) were
detected by applying electrical stimuli consisting of 10s, 20Hz
train, 1ms pulse duration, square wave monophasic stimuli,
starting at 0.2mA, at 0.1mA increments, delivered every 10min.
In addition, the occurrence and the severity of seizures in response
to the threshold stimulation was evaluated using the Racine (1972)
scale: (i) Motor arrest and twitching vibrissae; (ii) chewing, head
bobbing; (iii) forelimb clonus; (iv) forelimb clonus and rearing
and (v) rearing and falling.
FLX treatment
After the studies of seizures, depressive behaviour, and after-
discharge properties, both naive and post-SE animals underwent
FLX treatment. FLX (Spectrum Chemical, Gardena, CA, USA) was
injected once a day for 10 consecutive days, i.p. at a dose of
20mg/kg (Frankfurt et al., 1994; Hernandez et al., 2002;
Thompson et al., 2004). Control treatments consisted in daily
injections of vehicle (0.9% NaCl). One to two days after the end
of FLX administration, the animals underwent EEG monitoring, as
well as the behavioural and afterdischarge tests described earlier
(Fig. 1).
Fast cyclic voltammetry
One week after the end of second afterdischarge test, 5-HT release
from the hippocampus was electrochemically detected in vivo
using fast cyclic voltammetry (FCV) (Kennett and Joseph, 1982;
Jackson et al., 1995). Equipment included a scanning potentiostat
POT500 (WPI), MP100 amplifier/stimulator (BIOPAC) and a
computer equipped with AcqKnowledge 3.82 software (BIOPAC).
The three-electrode system consisted of working Nafion-coated
carbon fibre electrode (250m length, 10m diameter), Dri-Ref
reference electrode, and a platinum auxiliary electrode (all from
WPI). FCV was performed, as described elsewhere (Jackson et al.,
1995; Iravani and Kruk, 1997; Chuma et al., 2002), modified
according to the goal of the experiments, equipment and WPI
application notes.
Prior to each experiment, the carbon fibre electrode had been
sensitized to 5-HT. All three electrodes were immersed in
phosphate buffered saline (pH 7.4). Electrochemical treatment
consisted of triangular wave which was generated by MP100
stimulator function: 0 to +3.0V at 70Hz for 20s, 0 to +2.5V at
20Hz for 20s, 0 to +1.0V at 70Hz for 20s (WPI application
notes for carbon fibre electrodes). Sensitivity towards 5-HT was
confirmed by acquiring voltagrams from solutions of 5-HT,
norepinephrine or dopamine (Sigma) of known concentrations
(Fig. 2A). The voltammetric waveform consisted of a rest potential
0.2V scanned to 1V, then to  0.1V and then back to 0.2V,
at a rate of 1000V/s (Fig. 2, inset a), generated by MP100 sti-
mulator function, fed into the external input of the potentiostat
(Jackson et al., 1995).
5-HT release was examined in rats anaesthetized by urethane
(1.25mg/kg s.c, Sigma) and placed in stereotaxic device. Carbon
fibre electrode was inserted into CA1 (4.3mm posterior to
Bregma, 3mm lateral from midline, 3.6mm down from dura), or
CA3 (4.1mm posterior from Bregma, 4.2mm lateral from mid-
line, 4mm down from dura; Paxinos and Watson, 1986).
Auxiliary and reference electrodes were positioned on the surface
Depression after status epilepticus Brain (2008),131, 2071^2083 2073
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 of the dura and on the parietal area of the cranial bone,
respectively. Bipolar stimulating electrode (Plastics One) was
positioned into the dorsal raphe (7.8mm posterior from Bregma,
midline, 6.7mm ventral from dura; Paxinos and Watson, 1986;
Fig. 2B), a major source of serotonergic innervation of the
hippocampus (Azmitia and Segal, 1978). After acquisition of
background current (in the absence of raphe stimulation), 5-HT
release was induced by an electrical train applied to the
stimulating electrode using DS8000 stimulator (WPI): bipolar
square wave pulses, 100Hz, 200ms, 0.35mA (Jackson et al., 1995).
One second after the end of electrical stimulation, five consecutive
voltagrams were acquired with the intervals of 100ms. The
stimulation/acquisition cycle was repeated five times with 2.5min
intervals. The release of 5-HT was expressed as a peak amplitude
of Faradaic current, which represented the difference between
stimulation-induced and baseline current values (Iravani and
Kruk, 1997). Each voltagram used for the analysis represented an
average of five consecutive Faradaic currents acquired during
single acquisition cycle.
Validation of FCV in vivo was performed in a separate group of
rats in which 5-HT in the brain had been depleted by a selective
5-HT neurotoxin parachloroamphetamine (PCA, Sigma). We
previously showed that PCA treatment (60mg/kg i.p.) led to
nearly complete disappearance of 5-HT in the hippocampus
(Mazarati et al., 2005). In the present study, this method was used
to confirm the validity of FCV in vivo for detecting 5-HT release.
Four rats were injected with PCA (60mg/kg); FCV was performed
10 days after PCA administration.
High performance liquid chromatography
The 5-HT concentration and turnover in the hippocampus was
measured as described earlier (Mazarati et al., 2005). Immediately
after the end of FCV, animals were decapitated, brains removed
and hippocampi dissected on ice. Tissue samples were homo-
genized in the solution containing 0.09mol/l perchloric acid,
0.04mmol/l EDTA and 5mmol/l Sodium Bisulfite (1ml
per100mg of wet tissue), and centrifuged at 4 C and 16000G;
supernatant is stored at  70 C. Fifty aliquots, 50ml each, were
loaded onto the column. High performance liquid chromatog-
raphy (HPLC) was performed using with L-ECD-6A electro-
chemical detector (Shimadzu, Kyoto, Japan) and HR-80 column,
4.6 8 3mM (ESA Biosciences, Chelmsford, MA, USA). The
separation was done in isocratic elution mode using CAT-A-Phase
II mobile phase (ESA Biosciences). The measurements were done
at an electrode potential of +0.7V. Data were analysed using EZ
Start software (Shimadzu); areas under peaks were calculated and
plotted against the areas for the known concentration of the
standards. Two peaks were identified: 5-HT, and serotonin
metabolite 5-hydroxyindolacetic acid (5-HIAA). 5-HT turnover
was expressed as 5-HIAA/5-HT ratio (Zangen et al., 1997).
Data analysis
Data were analysed using Prizm 4 statistical software (GraphPad,
San Diego, CA, USA). The number of animals in experimental
groups and statistical tests used are indicated in the respective
results sections. For samples that had passed D’Agostino and
Pearson omnibus normality test, paired and unpaired t-tests, as
well as one-way analysis of variance (ANOVA) followed by post
hoc Bonferroni test were used were appropriate. For samples that
failed normality test, Mann–Whitney or Wilcoxon tests were
employed. P50.05 was accepted as an index of statistically
significant differences. Correlation analysis was performed using
Spearman correlation test.
Results
Spontaneous seizures
Four weeks after SE, prior to FLX treatment, 16 animals
were randomly divided into two groups (n=8 per group),
and underwent seizure monitoring for 1 week. In each of
the groups, seizures were observed in five animals. The
minimal/maximal/median seizure count over 1 week, was
0/5/1.5 in group 1 and 0/4/1.0 in group 2 (P40.05 between
the groups). After vehicle (group 1) and FLX (group 2)
treatment (8 weeks after SE), seizure incidence and
Fig. 2 Selectivity of carbon fibre electrodes and electrode
placement for fast cyclic voltammetry. (A) Selectivity of carbon
fibre electrode for 5-HTversus dopamine (DA) and norepinephrine
(NE).Triangular voltage waveform [0.2 to1to  0.1V,100 V/s, shown
in the inset (a) on the top of the graph] was applied to solutions
containing increasing concentrations of 5-HT (1^100mM),100mM
solutions of DA or NE.Graphs represent averages of five
consecutive Faradaic currents.Voltammetric response increased
as a function of 5-HT concentration. A response to DA and NE
at100mM was far below that to the lowest 5-HT concentration.
Inset (b) at the bottom of the graph shows peak Faradaic currents
plotted against decimal logarithmic concentrations of 5-HT .
(B) Leftçtarget location (arrows) of recording carbon fibre
electrodes in the CA1and CA3 of the hippocampus; rightçtarget
location (arrow) of stimulating electrode in dorsal raphe (DR).
Images are from Paxinos and Watson (1986).
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 frequency were within the same statistical range as during
the first monitoring session (Fig. 3B), although there was a
trend toward a decrease in seizure frequency in the FLX-
treated animals. In the vehicle treated group, seven animals
exhibited seizures, but after FLX, seizures were recorded in
all eight rats. The minimal/maximal/median seizure fre-
quency was 0/15/5 in vehicle-treated rats and 1/5/2 after
FLX administration (P40.05). During the two observation
periods combined, each of the animals exhibited at least
one seizure.
Afterdischarge properties
During the first test prior to FLX treatment, ADT was sig-
nificantly lower and ADD—significantly longer in post-SE
animals (two groups, n=8 each), as compared to controls
(two groups, n=7 each; Fig. 4A–D). Furthermore, in con-
trast to naive rats, post-SE animals developed behavioural
seizures in response to threshold stimulation (Fig. 4D).
In naive rats, treatment with FLX significantly elevated
ADT (from 1.1 0.14mA to 1.8 0.12mA, n=7,P50.05);
ADD was not affected by FLX treatment (Fig. 4C). Admin-
istration of FLX to post-SE animals (n=8) reversed the
increase of excitability which had been induced by SE.
Thus, ADT increased from 0.53 0.1mA before treat-
ment to 1.6 0.14mA after FLX; ADD shortened from
64 14.1s to 24.1 5.6s (P50.05 for both parameters,
Fig. 4D). Further, the severity of convulsions in response to
threshold stimulation decreased from 2.5 0.6 to 1.2 0.4
(P50.05, Fig. 4D).
Behavioural deficits
During the first test, prior to FLX treatment, the naive
animals exhibited a strong preference towards saccharin
solution over tap water (two groups, n=7 each; Fig. 5A). In
contrast to controls, post-SE animals consumed statistically
equal amounts of regular water and saccharin solution (two
groups, n=8 each; Fig. 5A). The introduction of saccharin
did not alter total volume of consumed fluid (saccharin +
regular water) in both control and post-SE rats (data not
shown). The administration of FLX did not modify
saccharin consumption in both the naive and post-SE
animals (Fig. 5A) nor change the total volume of consumed
fluid (data not shown).
Prior to FLX (n=7) or vehicle (n=7) treatment, total
immobility time in the naive rats was between 75s and
110s. In post- SE animals (two groups, n=8 each)
immobility time was between 90s and 210s. The increase
in immobility time after SE was statistically significant
(P50.05, Fig. 5B). Administration of FLX to naive rats
resulted in significant shortening of immobility time under
conditions of FST (from 80 4.6s to 48 3.5s P50.05,
Fig. 5B). However, similar treatment with FLX, did not
improve forced swim behaviour in post-SE animals: in this
group immobility time was 148 26s before, and
147 22s after FLX administration (Fig. 5B).
5-HTrelease from the hippocampus
Pre-treatment with PCA (n=4) led to 7-fold reduction of
5-HT release from the rat hippocampus, as compared to
naive rats (Fig. 6A and B), thus confirming the validity of
the used technique for detecting 5-HT release in vivo. In the
hippocampus of vehicle-treated post-SE animals (n=6) the
release of 5-HT in response to raphe stimulation was
significantly diminished as compared to vehicle-treated
controls (n=7). Chronic treatment with FLX did not affect
5-HT release in both control (n=7) and post-SE (n=7)
animals (Fig. 6A and B).
5-HT concentration and turnover in the
hippocampus
In hippocampal tissue of vehicle-treated post-SE animals
(n=6), both the concentration of 5-HT and its turnover
were significantly lower as compared to control rats (n=7;
Fig. 7). Chronic treatment with FLX did not alter 5-HT
concentration in hippocampi of both the naive (n=7) and
post-SE (n=7) rats. At the same time, FLX administration
to controls significantly inhibited 5-HT turnover.
Treatment of post-SE animals with FLX resulted in a
further decrease of the 5-HIAA/5-HT ratio, which was
lower than both the FLX-free post-SE group and the FLX-
treated control subjects (Fig. 7).
Fig. 3 Spontaneous seizures after SE and the effects of FLX.
(A) An example of spontaneous electrographic seizure 4 weeks
after SE. Arrows show the onset and the end of the seizure.
(B) Spontaneous seizure count during1-week recording periods
before and after FLX (vehicle in controls) treatment. Data are
presented as Mean SEM. No statistically significant differences
between the groups (Mann^Whitney test) and before^after
treatments (Wilcoxon test) were revealed.
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 Correlation analysis
In the absence of FLX treatment, no correlation was found
between the frequency of seizures and any of other para-
meters (Table 1). At the same time, animals with more
profound changes in afterdischarge properties exhibited
longer immobility time in the FST and lower preference
towards saccharin (Table 1). Furthermore, longer immobi-
lity time during FST was observed in animals with slower
5-HT turnover in, and release from the hippocampus.
However, parameters of serotonergic transmission were not
associated with changes in taste preference. Likewise, no
correlation was found between the extent of behavioural
changes in forced swim and taste preference tests. Finally,
no statistical association was revealed between the changes
in either of the two of afterdischarge indices and the extent
of serotonergic deficits (Table 1).
After FLX treatment, no correlation was observed between
both seizure frequency and afterdischarge properties on the
one hand and behavioural indices on the other hand
( 0.06 4 r 4 +0.065, P 40.05 for all pairs of variables).
Correlation between 5-HT turnover and behavioural
alterations in FST also disappeared after FLX administra-
tion (P 40.05); at the same time, correlation between
5-HT release from the hippocampus and the extent
of forced swim behavioural deficits was statistically signi-
ficant as it had been without FLX treatment (r= 0.81,
P50.05).
Discussion
Our experiments showed that SE led to behavioural and
biochemical impairments which were congruent with dep-
ression. The behavioural impairments included increased
immobility time under conditions of FST, which represe-
nted a model equivalent of despair, and the loss of taste
preference under conditions of saccharin consumption test,
Fig. 4 Changes in afterdischarge properties after SE and the effects of FLX treatment. (A and B)E x a m p l e so fa f t e r d i s c h a r g ei nn a i v e
(A)a n dp o s t - S E( B) animals. Horizontal bars and numbers on the top indicate test train and the applied current. Arrows indicate the
beginning and the end of afterdischarge.In the provided examples, in post-SE animal ADTwas nearly twice lower, and ADDç3-foldlonger,
than in naive rat. (C and D) Afterdischarge properties in naive (C)a n dp o s t - S E( D) groups. ADT is plotted on the bottom portion and
ADDçon the top portion of the left Y-axis; seizure score in response to threshold stimulation is plotted on the right Y-axis (D only).
Veh: vehicle. All data are presented as mean SEM.
 P50.05 versus ‘Before treatment’ (paired t-test for ADTand ADD; Wilcoxon test
for Seizure severity);
yP50.05 versus respective parameter and time point on C (one-way ANOVA + Bonferroni test).
2076 Brain (2008),131, 2071^2083 A. Mazarati et al.
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 which suggested the development of anhedonia-like symp-
tomatology. The decrease in 5-HT concentration, turnover
and release in the hippocampus suggested compromised
serotonergic transmission. Treatment with FLX using a
regiment which effectively prolonged active swimming
behaviour in naive animals and inhibited 5-HT metabolism
in both the naive and post-SE rats, reversed the SE-induced
increase in brain excitability, but failed to improve the
behavioural deficits associated with SE.
Status epilepticus leads to depression-like
behavioural impairments
Increased immobility time under conditions of FST has
been well established under conditions of animal models of
depression. The specified behavioural deficit was observed
in genetic models of depression both in rats (Zangen et al.,
1997) and mice (El Yacoubi et al., 2003). Increased
immobility time in FST was found in animals in which
depression had been induced by maternal separation (Lee
et al., 2007), and chronic food restriction (Jahng et al.,
2007). The increased immobility time in our studies
suggests that SE does indeed lead to the development of
a condition which can be interpreted as an experimental
correlate of a state of despair.
Anhedonia is one of key symptoms in depressed
individuals (Overstreet et al., 2005). In rats, examination
of anhedonia is based on the inherent preference towards
sweets (e.g. saccharin or sucrose solutions). Loss of taste
preference was observed in a mouse genetic model of
depression (El Yacoubi et al., 2003), as well as under
conditions of depression induced by chronic mild stress
(Willner, 1997). At the same time, Flinders Sensitive Line
rats (a genetic model of depression) did not exhibit loss of
taste preference (Overstreet et al., 2005).
In animal models of epilepsy, symptoms equivalent
to anhedonia have been reported only in few studies.
Fig. 5 Changes in behaviour after SE and the effects of FLX
treatment. (A) Saccharin consumption.Taste preference is
expressed as percent of volume of saccharin solution of a total
fluid (water + saccharin) consumed over 24h.
zP50.05 versus
percent of consumed regular water (one-way ANOVA +
Bonferroni test);
yP50.05 versus naive animals (one-way
ANOVA + Bonferroni test). (B)F S T .
 P50.05 versus before
FLX (paired t-test);
yP50.05 versus naive animals (one-way
ANOVA +Bonferroni test).Veh=vehicle. Data are presented as
mean SEM.
Fig. 6 5-HTrelease from the hippocampus in response to raphe
stimulation and the effects of FLX treatment. (A)M e a n SEM
Faradaic currents under CA1 and CA3 carbon fibre electrodes in
response to dorsal raphe stimulation.
 P50.05 versus respective
group indicated by connecting line (one-way ANOVA + Bonferroni
test). (B) Examples of Faradaic currents recorded from control,
post-SE and PCA-treated rats.
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 Thus, reduced sucrose preference was reported in Wag-Rij
rats, a model of absence epilepsy (Sarkisova et al., 2003).
We recently reported the loss of taste preference in kindled
animals (Mazarati et al., 2007). The loss of taste preference
observed in post-SE rats represents another behavioural
symptom of depression in animals during chronic epileptic
state.
Deficits of serotonergic transmission and
depression
Dysfunction in serotonergic transmission, including that in
the hippocampus, has been regarded as factor contributing
in depression (Theodore, 2003). However, there is no
agreement as to the direction in which 5-HT concentration,
turnover and release are altered both in patients with
depression and under conditions of animal models.
In the laboratory setting, increased 5-HT and 5-HIAA
concentration, and unaltered 5-HIAA/5-HT ratio in the
hippocampus was reported in Finders Sensitive Line rats
(Zangen et al., 1997). 5-HT concentration (Gronli et al.,
2007) and release (Bianchi et al., 2003) appeared to be
intact under conditions of depression induced by stress. At
the same time, a mouse genetic model of depression was
characterized by the inhibition of 5-HT turnover in the
hippocampus, as well as by the reduced firing of sero-
tonergic neurons in raphe nucleus (El Yacoubi et al., 2003).
Decline of 5-HT concentration in the rat hippocampus was
Table 1 Correlation analysis between spontaneous seizures, brain excitability, behavioural and biochemical impairments
after status epilepticus
Seizure
count
(1 week)
Afterdischarge
threshold/duration
5-HIAA/5-HT
(HPLC)
5-HT
release
(FCV),CA1 CA3/2
FST-immobility
time
Per cent
saccharin
intake
Seizure count (1week) r=+0 .55 r=-0 .5 9 r= 0.59 r=+0 . 46 r= 0.62
P40.05 P40.05 P40.05 P40.05 P40.05
Afterdischarge threshold/duration r(t)=+0 .64 r(t)=+0 . 63 r(t)=20.86 r(t)=+0.77
r(d)= 0.66 r(d)= 0.52 r(d)=+0.82 r(d)=20.75
P40.05 P40.05 P_0.05 P_0.05
5-HIAA/5-HT (HPLC) r=+0.84 r=20.89 r=+0 .56
P_0.05 P_0.05 P40.05
5-HTrelease(FCV) r= 0.85 r=+0 . 68
P_0.05 P40.05
FST-immobility time r=+0 . 6 9
P40.05
All parameters were evaluatedin the group of animals (n=6) in the absence of FLX treatment.Data on FLX-treated animals are discussed
in Results.Coefficient of correlation (‘+r’   positive;‘ r’   negative correlation) and its statistical significance were calculated using
Spearman correlation.In the afterdischarge threshold/duration row, r(t) = afterdischarge threshold, r(d) = afterdischarge duration.For FCV,
averages of CA1and CA3 values were used, since values of the two indices were statistically similar (Fig. 6). Statistically significant
correlation is indicated by bold italic font.
Fig. 7 5-HT concentration and turnover in the hippocampus, and the effects of FLX treatment. Data are shown as mean SEM for
control and post-SE groups, both vehicle and FLX-treated. 5-HT concentration is plotted on the left, and turnoverçon the right Y-axis.
 P50.05 versus respective group as indicated by connecting line (one-way ANOVA + Bonferroni test).
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 reported under conditionsofdepressioninducedbymaternal
separation (Lee et al., 2007), olfactory bulbectomy (Xu et al.,
2005) and chronic food restriction (Jahng et al., 2007). In
addition, inhibition of both 5-HT turnover and release in the
hippocampus was reported under conditions of depression
induced by forced swimming (Adell et al., 1997; Kirby et al.,
1997) and olfactory bulbectomy (Xu et al., 2005).
In human studies, no differences were reported in
hippocampal 5-HT, 5-HIAA and 5-HIAA/5-HT ratio
between depressed suicide victims and age-matched con-
trols (Cheetham et al., 1989). At the same time, the reduc-
tion of 5-HT, 5-HIAA and 5-HT turnover in the brainstem
of depressed suicide patients has been well established
(Mann et al., 1989). Since raphe serotonergic neurons
represent a major source of hippocampal 5-HT (Azmitia
and Segal, 1978), deficient serotonergic transmission in
raphe suggests that hippocampal serotonergic innervation
might be compromised. With this regard, reduced 5-HT
release from the hippocampus in response to raphe sti-
mulation observed in our post-SE animals is in line with
the discussed human findings. Furthermore, because sero-
tonin is not synthesized in the hippocampus, but rather
represents axonal pool of 5-HT neurons located in raphe
nuclei (Azmitia and Segal, 1978), the observed reduction of
5-HT concentration in post-SE animals likely reflects
compromised neurotransmitter signalling along the raphe-
hippocampal serotonergic pathway, which was demon-
strated in our experiments by means of the FCV technique.
Deficits of serotonergic transmission and
epilepsy
There are some clinical and experimental data available as
to the 5-HT concentration and metabolism under condi-
tions of epilepsy. Thus, the increase of 5-HT metabolism
was shown in actively spiking hippocampal and cortical
samples from TLE patients (Louw et al., 1989). At the same
time, patients with mesial TLE had decreased 5-HT release
from the hippocampus, as compared with patients with
neocortical temporal lobe epilepsy (Broderick et al., 2000).
No changes in hippocampal 5-HT concentration were
revealed in the rat chronic epilepsy model induced by
pilocarpine SE (Cavalheiro et al., 1994; Szyndler et al.,
2005). However, chronic epileptic state induced by kindling
was associated with the inhibition of hippocampal 5-HT
metabolism (Szyndler et al., 2002a). The discrepancy
between the decrease of 5-HT concentration and metabo-
lism observed in our experiments, and the lack of changes
reported in other studies, as well as differences observed for
two different epilepsy models (Szyndler et al., 2002a; 2005),
are difficult to address, given overall limited experimental
data. One noticeable difference between our and earlier
studies are different ages at the time of precipitating insult:
while Szyndler et al., (2005) and Cavalheiro et al. (1994)
used adult rats, we used animals of peri-adolescent age
(postnatal day 35) at the time of SE.
Mechanisms of the observed inhibition of 5-HT turnover
(5-HIAA/5-HT ratio) in post-SE hippocampus require
further exploration. Several studies found reduced expres-
sion of serotonin reuptake transporter (SERT) in raphe
nuclei of animals with induced depression (Jahng et al.,
2007; Lee et al., 2007). The data on the alterations of SERT
in the hippocampus under conditions of TLE are limited.
Thus, decrease of SERT binding was observed in the
hippocampus after amygdala (Clark et al., 1993) and
pentylenetetrazole (Szyndler et al., 2002b) kindling. Rocha
et al. (2007) found reduced SERT binding in the neocortex
of patients with TLE. The association between the polymor-
phism of SERT gene and TLE has been discussed (Manna
et al., 2007). The inhibition of 5-HT reuptake due to the
downregulation of hippocampal SERT would explain the
decrease of 5-HT turnover: indeed, the reduction of intra-
cellular pool of transmitter amenable to the monoamine
oxidase would limit the formation of 5-hydroxy-indol-
acetaldehyde and subsequent oxidation of the latter to
5-HIAA.
Lack of the effects of fluoxetine on depressive
behaviour following status epilepticus
The increase in active swimming behaviour in response to
FLX treatment was reported both under conditions of
classic (Page et al., 1999), and modified (Pucilowski and
Overstreet, 1993; Overstreet et al., 1995) Porsolt tests. In
our experiments, the validity of FST was confirmed in naive
animals, which exhibited significant reduction of the immo-
bility time after FLX treatment. The fact that post-SE rats
did not show an improvement in forced swim behaviour
after similar FLX administration implies that depression in
epileptic animals is mechanistically different from behav-
iourally similar condition which is regulated by SSRI.
FLX reduced intake of saccharin solutions both in naive
Long–Evans (Leander, 1987) and in alcohol-preferring FH/
WJD rats (Kampov-Polevoy and Rezvani, 1997), possibly as
a consequence of curbing the appetite. In line with such
suggestion, Overstreet et al. (2007) found that FLX in a
dose that reduced immobility time under conditions of FST
did not affect alcohol consumption in FH/WJD rats, thus
implying that the drug did not affect reward pathways. At
the same time, Muscat et al. (1992) reported attenuation of
stress-induced anhedonia by FLX in Lister rats. It might be
problematic to dissociate between appetite- and pleasure-
related effects of saccharin solution in rats. In fact, we
previously reported the dissociation between calorie-free
saccharin and calorie-containing sucrose intake in kindled
Wistar animals (Mazarati et al., 2007). It is possible that in
the Wistar strain saccharin consumption predominantly
tests pleasure experience instead of appetite. If the latter is
true, FLX could be expected to increase saccharin intake;
however, because of high baseline saccharin preference in
naive animals, such an effect might be difficult to detect.
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 Regulation of serotonergic transmission
by fluoxetine
In line with previous reports (Thompson et al., 2004), in
our studies FLX inhibited 5-HT turnover in the hippo-
campus of naive animals without affecting 5-HT concen-
tration. Reduced 5-HIAA concentration after FLX treatment
is due to the inhibition of 5-HT reuptake and, as discussed
earlier, subsequent decrease of the intracellular fraction of
transmitter available for monoamine oxidase—mediated
metabolism of 5-HT. Furthermore, in post-SE animals FLX
further inhibited already reduced 5-HT turnover. Such
additive effect of SE and FLX treatment imply a common
underlying mechanism, thus supporting our suggestion that
reduction of 5-HIAA/5-HT ratio in animals with epilepsy
might result from the inhibition 5-HT reuptake.
Effects of fluoxetine on seizures and
neuronal excitability
There is some evidence that FLX might exert anticonvulsant
effects. Thus, Albano et al. (2006) reported reduction of
frequency of complex partial seizures in patients after
introduction of FLX to conventional anti-epilepsy drug
treatment. In the laboratory setting, Hernandez et al. (2002)
reported inhibition of spontaneous recurrent seizures by
FLX in post-SE animals. In our studies, we did not find
statistically significant effect of FLX treatment on seizure
frequency. However, in contrast to Hernandez et al. (2002),
we did not examine the direct effect of FLX administration
on seizures; instead seizure frequency was examined after
completion of FLX therapy. Nevertheless, our treatment
regimen resulted in a post-treatment decrease of brain
excitability as measured by AD properties. This finding
agrees with the data of Wada et al. (1995), that the anti-
convulsant effects of FLX on seizures induced by hippo-
campal stimulation were observed only after chronic
treatment, and persisted for 1 week after the end of FLX
administration. Another possible reason as to why FLX
administration failed to affect spontaneous seizures is that
baseline seizures frequency in our study was relatively low,
which could prohibit revealing modifying effects of thera-
peutic interventions. This low frequency of spontaneous
seizures might be attributed to the younger age at which
our animals were subjected to SE. Indeed, a positive cor-
relation between the age of the precipitating insult and the
subsequent frequency of spontaneous seizures has been
reported (Sankar et al., 2000).
Insights from correlation analysis
Since statistical correlation does not imply causative rela-
tionship between the observed phenomena, the results of
correlation analysis should be interpreted with caution.
Nevertheless, our observations allow drawing several
conclusions.
First, the frequency of spontaneous seizures translated
into neither behavioural, nor serotonergic deficits. This
finding was congruent with several clinical observations, in
which alleviation of seizures through surgical resection of
epileptic foci did not improve symptomatology of depres-
sion in epilepsy patients (Spencer et al., 2003; Wrench
et al., 2004). Second, the increase of brain excitability which
was revealed in afterdischarge tests, may contribute to
depression-like behavioural impairments. Similar correla-
tion was reported under conditions of kindling model of
epilepsy (Mazarati et al., 2007). Third, correlation between
biochemical alterations and forced swim behaviour suggests
that hippocampal serotonergic dysfunction may also
contribute to state of helplessness associated with depres-
sion. At the same time, lack of correlation between changes
in serotonergic transmission in the hippocampus and the
reduction of taste preference suggests the involvement of
extrahippocampal and/or non-serotonergic mechanisms in
modulating such behaviour (e.g. mesolimbic system and
hypothalamus, Nestler and Carlezon, 2006). Fourth, stat-
istical dissociation between afterdischarge properties and
serotonergic transmission implies that these two changes
may independently evolve and lead to the same set of
depressive behavioural alterations. The latter suggestion
emphasizes the complexity and multiplicity of the mecha-
nisms of depression associated with epileptic state. Such
complexity is further stressed by the absence of correlation
between changes in forced swim and taste preference
behaviours.
Assuming that the discussed statistical correlations
indeed reflect several independent mechanistic links
between changes in hippocampal excitability and behav-
ioural impairments, and concurrently between serotonergic
deficiency and behavioural disorders, the question remains
whether altered afterdischarge properties and changes in
serotonergic transmission have a common denominator.
One important issue not explored in our study is a possible
contribution of post-SE neuronal injury (as well as of an
ongoing injury resulting from recurrent seizures) in the
development of the reported physiological, biochemical and
behavioural phenomena. Our previous studies using rapid
kindling model (Mazarati et al., 2007) proved that
behavioural symptoms of depression may develop in the
absence of neuronal injury, since the latter is not found
under conditions of rapid kindling (Mazarati, unpublished
data). This observation, however does not exclude the pos-
sibility that in post-SE models, mechanisms of depression-
like behaviour might differ from those in non-lesional
model(s) of epileptic state. In the present study we did not
examine spatial distribution of neuronal injury after SE,
since brain tissue was used for biochemical assays.
However, it is well established that pilocarpine SE leads
to a wide-spread injury to the hippocampus, as well
as to extrahippocampal and extralimbic areas (Cavalheiro
et al., 2006), some of which are likely involved in the
regulation of mood and mechanisms of depression
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 (Shumake and Gonzalez-Lima, 2003; Kanner, 2005;
Kondziella et al., 2007). The contribution of neuronal
injury in both epilepsy-associated depressive behaviour and
deficient serotonergic transmission is quite possible; parti-
cularly, the failure of FLX to improve forced swim
behaviour in post-SE animals may be due to the fact that
this symptom is a result of neurodegeneration. However,
the complexity of the mentioned connection requires
separate line of experiments which should employ detailed
histopathological (and/or functional) mapping.
Concluding remarks
Validation of animal models of comorbidity of TLE and
depression is complicated by several factors. Both beha-
vioural and biochemical correlates of depression are diverse
and multifaceted; therefore selecting the best hallmarks is
difficult, particularly because many of the putative signal-
ling pathways are involved in both depression and epilepsy.
Furthermore, clinical relevance of behavioural indicators of
mood in experimental animals should be approached with
caution. Thus, validation of animal models of comorbidity
ideally should include comprehensive analysis of complex
behaviours (e.g. sleep, reward, appetite, etc.), as well studies
of various signalling candidates (e.g. hypothalamic–pitui-
tary–adrenal axis, other monoamines, peptides, etc.). As an
initial step in this direction, our study provides evidence
that the post-SE model of TLE leads to behavioural
(equivalents of despair and anhedonia) and biochemical
(compromised 5-HT transmission) alterations suggestive of
depression. Furthermore, resistance of symptoms of depres-
sion in epileptic animals to an antidepressant medication
implies distinct mechanisms of depression in epilepsy,
beyond alterations in serotonergic pathways. Finally, cor-
relation analysis suggests that depression associated with
epilepsy has multiple underlying mechanisms, which if
proven true, should be considered in the development of
therapeutic interventions.
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